Generic Drug Price Inflation Tackled In Congressional Budget Deal

A provision in the Bipartisan Budget Act of 2015 will require that generic drug manufacturers pay additional rebates to Medicaid if prices increase faster than inflation, as manufacturers of single-source brands do.